The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Open accessAbstract
One year into the global COVID-19 pandemic, the focus of attention has shifted to the emergence and spread of SARS-CoV-2 variants of concern (VOCs). After nearly a year of the pandemic with little evolutionary change affecting human health, several variants have now been shown to have substantial detrimental effects on transmission and severity of the virus. Public health officials, medical practitioners, scientists, and the broader community have since been scrambling to understand what these variants mean for diagnosis, treatment, and the control of the pandemic through nonpharmaceutical interventions and vaccines. Here we explore the evolutionary processes that are involved in the emergence of new variants, what we can expect in terms of the future emergence of VOCs, and what we can do to minimise their impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of bacteria from virus sensitivity to virus resistance
Luria, S. E., & Delbrück, M. (1943) · Genetics · doi:10.1093/genetics/28.6.491 · Cited by 3,894
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · doi:10.1101/2021.05.22.21257658 · Cited by 2,888
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Superspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514
Detection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. D. S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., et al. (2021) · Science · doi:10.1126/science.abh2644 · Cited by 1,461
Frank, S. A. (1996) · The Quarterly Review of Biology · doi:10.1086/419267 · Cited by 1,388
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Choi, B., Choudhary, M. C., Regan, J., Sparks, J. A., Padera, R. F., Qiu, X., Solomon, I. H., Kuo, H.-H., Boucau, J., Bowman, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2031364 · Cited by 1,246
Woolhouse, M. E. J., Dye, C., Etard, J.-F., Smith, T., Charlwood, J. D., Garnett, G. P., Hagan, P., Hii, J. L. K., Ndhlovu, P. D., Quinnell, R. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.338 · Cited by 1,194
Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00432-3 · Cited by 1,119
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097 · cited 4×
“If overdispersion arises because individuals vary in infectivity, with some cases transmitting much less often and others much more often than expected (for example, ‘super-spreaders’), then this variability tends to decrease the probability of establishment of a variant 27 (Figure 1 Illustrated here is a predominantl…”
InfluentialIncreased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
CMMID COVID-19 Working Group, Davies, N. G., Jarvis, C. I., Edmunds, W. J., Jewell, N. P., Diaz-Ordaz, K., & Keogh, R. H. (2021) · Nature · doi:10.1038/s41586-021-03426-1 · Cited by 921
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Abu-Raddad, L. J., Chemaitelly, H., & Butt, A. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2104974 · Cited by 899
Challen, R., Brooks-Pollock, E., Read, J. M., Dyson, L., Tsaneva-Atanasova, K., & Danon, L. (2021) · BMJ · doi:10.1136/bmj.n579 · Cited by 776
Avanzato, V. A., Matson, M. J., Seifert, S. N., Pryce, R., Williamson, B. N., Anzick, S. L., Barbian, K., Judson, S. D., Fischer, E. R., Martens, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.049 · Cited by 716
Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706
(2020) · doi:10.3138/jammi-2020-0030 · Cited by 664
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Deng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-González, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.025 · Cited by 651
Damas, J., Hughes, G. M., Keough, K. C., Painter, C. A., Persky, N. S., Corbo, M., Hiller, M., Koepfli, K.-P., Pfenning, A. R., Zhao, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010146117 · Cited by 633
Meyerowitz-Katz, G., & Merone, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1464 · Cited by 566
Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China
Endo, A., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, Abbott, S., Kucharski, A. J., & Funk, S. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15842.3 · Cited by 555
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021) · Science · doi:10.1126/science.abf6950 · Cited by 535
The Evolution and Emergence of RNA Viruses
Holmes, E. C. (2009) · doi:10.1093/oso/9780199211128.001.0001 · Cited by 452
Evidence for transmission of COVID-19 prior to symptom onset
Tindale, L. C., Stockdale, J. E., Coombe, M., Garlock, E. S., Lau, W. Y. V., Saraswat, M., Zhang, L., Chen, D., Wallinga, J., & Colijn, C. (2020) · eLife · doi:10.7554/elife.57149 · Cited by 452
Self-citationSerum Neutralizing Activity Elicited by mRNA-1273 Vaccine
Wu, K., Werner, A. P., Koch, M., Choi, A., Narayanan, E., Stewart-Jones, G. B. E., Colpitts, T., Bennett, H., Boyoglu-Barnum, S., Shi, W., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102179 · Cited by 409
Lenski, R. E., & May, R. M. (1994) · Journal of Theoretical Biology · doi:10.1006/jtbi.1994.1146 · Cited by 404
Choi, A., Koch, M., Wu, K., Chu, L., Ma, L., Hill, A., Nunna, N., Huang, W., Oestreicher, J., Colpitts, T., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01527-y · Cited by 396
SARS-CoV-2 within-host diversity and transmission
Lythgoe, K. A., Hall, M., Ferretti, L., de Cesare, M., MacIntyre-Cockett, G., Trebes, A., Andersson, M., Otecko, N., Wise, E. L., Moore, N., et al. (2021) · Science · doi:10.1126/science.abg0821 · Cited by 383
Brault, A. C., Huang, C. Y.-H., Langevin, S. A., Kinney, R. M., Bowen, R. A., Ramey, W. N., Panella, N. A., Holmes, E. C., Powers, A. M., & Miller, B. R. (2007) · Nature Genetics · doi:10.1038/ng2097 · Cited by 341
Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China
Endo, A., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, Abbott, S., Kucharski, A. J., & Funk, S. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15842.1 · Cited by 328
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
van Dorp, L., Richard, D., Tan, C. C. S., Shaw, L. P., Acman, M., & Balloux, F. (2020) · Nature Communications · doi:10.1038/s41467-020-19818-2 · Cited by 319
A human coronavirus evolves antigenically to escape antibody immunity
Eguia, R., Crawford, K. H. D., Stevens-Ayers, T., Kelnhofer-Millevolte, L., Greninger, A. L., Englund, J. A., Boeckh, M. J., & Bloom, J. D. (2020) · doi:10.1101/2020.12.17.423313 · Cited by 258
A human coronavirus evolves antigenically to escape antibody immunity
(2021) · doi:10.1371/journal.ppat.1009453 · Cited by 258
Althouse, B. M., Wenger, E. A., Miller, J. C., Scarpino, S. V., Allard, A., Hébert-Dufresne, L., & Hu, H. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000897 · Cited by 252
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Saad-Roy, C. M., Morris, S. E., Metcalf, C. J. E., Mina, M. J., Baker, R. E., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Levin, S. A., et al. (2021) · Science · doi:10.1126/science.abg8663 · Cited by 220
Skelly, D. T., Harding, A. C., Gilbert-Jaramillo, J., Knight, M. L., Longet, S., Brown, A., Adele, S., Adland, E., Brown, H., Team, M. L., et al. (2021) · doi:10.21203/rs.3.rs-226857/v2 · Cited by 216
(2021) · doi:10.1038/s41467-021-25167-5 · Cited by 216
On the evolutionary epidemiology of SARS-CoV-2
Day, T., Gandon, S., Lion, S., & Otto, S. P. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.031 · Cited by 205
Self-citationWhy does drug resistance readily evolve but vaccine resistance does not?
Kennedy, D. A., & Read, A. F. (2017) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2016.2562 · Cited by 192
Bull, J. J. (1994) · Evolution · doi:10.1111/j.1558-5646.1994.tb02185.x · Cited by 188
Applying population‐genetic models in theoretical evolutionary epidemiology
Day, T., & Gandon, S. (2007) · Ecology Letters · doi:10.1111/j.1461-0248.2007.01091.x · Cited by 171
Self-citationVirulence evolution and the timing of disease life-history events
Day, T. (2003) · Trends in Ecology & Evolution · doi:10.1016/s0169-5347(02)00049-6 · Cited by 168
Self-citationOgden, N. H., Wilson, J. R., Richardson, D. M., Hui, C., Davies, S. J., Kumschick, S., Roux, J. J. L., Measey, J. G., Saul, W., & Pulliam, J. R. C. (2019) · Royal Society Open Science · doi:10.1098/rsos.181577 · Cited by 156
Self-citationLarsen, H. D., Fonager, J., Lomholt, F. K., Dalby, T., Benedetti, G., Kristensen, B., Urth, T. R., Rasmussen, M., Lassaunière, R., Rasmussen, T. B., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.5.210009 · Cited by 154
The effectiveness of backward contact tracing in networks
Kojaku, S., Hébert‐Dufresne, L., Mones, E., Lehmann, S., & Ahn, Y. (2021) · Nature Physics · doi:10.1038/s41567-021-01187-2 · Cited by 142
The emerging plasticity of SARS-CoV-2
McCormick, K. D., Jacobs, J. L., & Mellors, J. W. (2021) · Science · doi:10.1126/science.abg4493 · Cited by 140
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Cobey, S. E., Larremore, D. B., Grad, Y. H., & Lipsitch, M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00544-9 · Cited by 120
Braun, K. M., Moreno, G. K., Wagner, C., Accola, M. A., Rehrauer, W. M., Baker, D., Koelle, K., O’Connor, D. H., Bedford, T., Friedrich, T. C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009849 · Cited by 120
Teruel, N., Mailhot, O., & Najmanovich, R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009286 · Cited by 105
Recombinant SARS-CoV-2 genomes circulated at low levels over the first year of the pandemic
VanInsberghe, D., Neish, A. S., Lowen, A. C., & Koelle, K. (2021) · Virus Evolution · doi:10.1093/ve/veab059 · Cited by 102
Teran, R. A., Walblay, K., Shane, E. L., Xydis, S. N., Gretsch, S. R., Gagner, A., Samala, U., Choi, H., Zelinski, C., & Black, S. R. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7017e1 · Cited by 99
Synonymous mutations and the molecular evolution of SARS-CoV-2 origins
Wang, H., Pipes, L., & Nielsen, R. (2020) · Virus Evolution · doi:10.1093/ve/veaa098 · Cited by 91
Calistri, P., Amato, L., Puglia, I., Cito, F., Giuseppe, A. D., Danzetta, M. L., Morelli, D., Domenico, M. D., Caporale, M., Scialabba, S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.005 · Cited by 84
Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster
Wu, K., Choi, A., Koch, M., Ma, L., Hill, A., Nunna, N., Huang, W., Oestreicher, J., Colpitts, T., Bennett, H., et al. (2021) · doi:10.1101/2021.05.05.21256716 · Cited by 84
Invasion thresholds and the evolution of nonequilibrium virulence
Bull, J. J., & Ebert, D. (2008) · Evolutionary Applications · doi:10.1111/j.1752-4571.2007.00003.x · Cited by 83
Risk factors for the evolutionary emergence of pathogens
Alexander, H. K., & Day, T. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0123 · Cited by 83
Self-citationVaccine rollout strategies: The case for vaccinating essential workers early
Mulberry, N., Tupper, P. F., Kirwin, E. M., McCabe, C. J., & Colijn, C. (2021) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000020 · Cited by 69
Self-citationOngoing Recombination in SARS-CoV-2 Revealed through Genealogical Reconstruction
Ignatieva, A., Hein, J., & Jenkins, P. A. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac028 · Cited by 59
Extended interval BNT162b2 vaccination enhances peak antibody generation
Parry, H., Bruton, R., Stephens, C., Bentley, C., Brown, K., Amirthalingam, G., Hallis, B., Otter, A., Zuo, J., & Moss, P. (2022) · npj Vaccines · doi:10.1038/s41541-022-00432-w · Cited by 52
Tang, B., Scarabel, F., Bragazzi, N. L., McCarthy, Z., Glazer, M., Xiao, Y., Heffernan, J. M., Asgary, A., Ogden, N. H., & Wu, J. (2020) · Biology · doi:10.3390/biology9050100 · Cited by 51
Self-citationGenomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene
Takada, K., Ueda, M. T., Shichinohe, S., Kida, Y., Ono, C., Matsuura, Y., Watanabe, T., & Nakagawa, S. (2023) · iScience · doi:10.1016/j.isci.2023.106210 · Cited by 38
Population Genomics Insights into the First Wave of COVID-19
Vasilarou, M., Alachiotis, N., Garefalaki, J., Beloukas, A. I., & Pavlidis, P. (2021) · Life · doi:10.3390/life11020129 · Cited by 30
Watson, O., Abdelmagid, N., Ahmed, A., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/84283 · Cited by 29
Ludwig, A., Berthiaume, P., Orpana, H., Nadeau, C., Diasparra, M., Barnes, J., Hennessy, D. A., Otten, A., & Ogden, N. H. (2020) · Canada Communicable Disease Report · doi:10.14745/ccdr.v46i1112a08 · Cited by 22
Self-citationFundamental limitations of contact tracing for COVID-19
Tupper, P. F., Otto, S. P., & Colijn, C. (2021) · FACETS · doi:10.1139/facets-2021-0016 · Cited by 17
Self-citationNo detectable signal for ongoing genetic recombination in SARS-CoV-2Preprint
Richard, D., Owen, C. J., van Dorp, L., & Balloux, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.15.422866 · Cited by 15
Modelling the impact of shutdowns on resurging SARS-CoV-2 transmission in Canada
Ng, V., Fazil, A., Waddell, L. A., Turgeon, P., Otten, A., & Ogden, N. H. (2021) · Royal Society Open Science · doi:10.1098/rsos.210233 · Cited by 12
Self-citationBraun, K. M., Moreno, G. K., Wagner, C., Accola, M. A., Rehrauer, W. M., Baker, D., Koelle, K., O’Connor, D. H., Bedford, T., Friedrich, T. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.30.440988 · Cited by 10
Cited by
Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E., Mallal, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.015 · Cited by 858
The origins of SARS-CoV-2: A critical review
Holmes, E. C., Goldstein, S. A., Rasmussen, A. L., Robertson, D. L., Crits-Christoph, A., Wertheim, J. O., Anthony, S. J., Barclay, W. S., Boni, M. F., Doherty, P. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.017 · Cited by 509
Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N., & Bull, R. A. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2381 · Cited by 474
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K., Ratzan, S. C., Parsons Leigh, J., Hu, J., & El-Mohandes, A. (2022) · Nature Communications · doi:10.1038/s41467-022-31441-x · Cited by 449
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics
Zvyagin, M., Brace, A., Hippe, K., Deng, Y., Zhang, B., Bohorquez, C. O., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., et al. (2023) · The International Journal of High Performance Computing Applications · doi:10.1177/10943420231201154 · Cited by 120
Metadata
- Authors
- Otto, S. P., Day, T., Arino, J., Colijn, C., Dushoff, J., Li, M., Mechai, S., Van Domselaar, G., Wu, J., Earn, D. J. D., & Ogden, N. H.
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 31
- Issue
- 14
- Pages
- R918-R929
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W3174720288
- Cited by
- 323
- References
- 74
- FWCI
- 21.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.